A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol
- PMID: 27493757
- PMCID: PMC4973537
- DOI: 10.1186/s12878-016-0058-4
A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol
Abstract
Background: Sickle cell disease (SCD) is endemic in non-Western countries. Due to migration, the prevalence of SCD in the Netherlands has increased. Adherence to medical treatment is recognized as a major problem area. Therefore, new effective interventions to increase adherence are urgently needed.
Methods/design: The TEAM study is an ongoing randomized controlled trial (RCT) to compare protocolized individual medical appointments (IMA's; care-as-usual) with protocolized group medical appointments (GMA's; novel intervention) in pediatric (n = 40) and adult (n = 60) patients. The study aims to assess the effectiveness of GMA's (over a three year period) on patients' self-efficacy, adherence, quality of life, morbidity, hospital admissions and satisfaction with the treating professional; as well as to test the cost-effectiveness of GMA's. In both the IMA and GMA groups structured assessments will be performed at baseline (start of the study), after 1.5 and after 3 years.
Discussion: This is the first RCT to investigate the effectiveness of GMA's on self-efficacy and adherence in pediatric and adult patients with SCD, including a cost-effectiveness analysis.
Trial registration: NTR4750 (NL42182.000.12). Registered 13 August 2014.
Keywords: Adherence; Cost-effectiveness; Group medical appointment; Randomized controlled trial; Self-efficacy; Sickle cell disease.
References
-
- Fox P, Ingram D. Theory and practice of self-induced pain management: approaches learned from effective copers. J Black Psychol. 1999;25:427–52. doi: 10.1177/0095798499025003009. - DOI
-
- Peters M, Appel IM, Cnossen MH, Breuning-Boers JM, Heijboer H. Sikkelcelziekte in de hielprikscreening. Ned Tijdschr Geneeskd. 2009;153:359. - PubMed
-
- Peters M, Fijnvandraat K, Van Den Tweel XW, Garre FG, Giordano PC, Van Wouwe JP, Pereira RR, Verkerk PH. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening. Arch Dis Child. 2010;95:822–5. doi: 10.1136/adc.2009.165290. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
